Journey Medical Expects Topline Results from Phase 3 Clinical Trials Evaluating DFD-29 for Treatment of Papulopustular Rosacea to be Announced Week of July 10

Your email address will not be published. Required fields are marked *

Comment

Website

Save my name, email, and website in this browser for the next time I comment.

Sign me up for the newsletter!

Δ